Journal
Journal of Experimental Medicine
Publication Date
2013
Volume
210
Issue
2
First Page
339
Last Page
353
Document Type
Open Access Publication
DOI
10.1084/jem.20121357
Rights and Permissions
Gautier EL, Westerterp M, Bhagwat N, Cremers S, Shih A, Abdel-Wahab O, Lütjohann D, Randolph GJ, Levine RL, Tall AR, Yvan-Charvet L. HDL and Glut1 inhibition reverse a hypermetabolic state in mouse models of myeloproliferative disorders. J Exp Med. 2013 Feb 11;210(2):339-53. doi: 10.1084/jem.20121357. Epub 2013 Jan 14. © 2013 Gautier et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
Recommended Citation
Gautier, Emmanuel L.; Westerterp, Marit; Bhagwat, Neha; Cremers, Serge; Shih, Alan; Abdel-Wahab, Omar; Lütjohann, Dieter; Randolph, Gwendalyn J.; Levine, Ross L.; Tall, Alan R.; and Yvan-Charvet, Laurent, "HDL and Glut1 inhibition reverse a hypermetabolic state in mouse models of myeloproliferative disorders." Journal of Experimental Medicine. 210, 2. 339 - 353. (2013).
https://digitalcommons.wustl.edu/open_access_pubs/8533
